Published in Toxins (Basel) on May 17, 2016
Interaction between TNF and BmooMP-Alpha-I, a Zinc Metalloprotease Derived from Bothrops moojeni Snake Venom, Promotes Direct Proteolysis of This Cytokine: Molecular Modeling and Docking at a Glance. Toxins (Basel) (2016) 0.75
Fine Tuning Cell Migration by a Disintegrin and Metalloproteinases. Mediators Inflamm (2017) 0.75
Cross-recognition of a pit viper (Crotalinae) polyspecific antivenom explored through high-density peptide microarray epitope mapping. PLoS Negl Trop Dis (2017) 0.75
Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science (2002) 12.29
A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature (1997) 10.14
Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature (2002) 8.28
Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature (2001) 6.95
von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med (1998) 6.17
Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem (1998) 6.14
Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature (1997) 6.06
Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med (1998) 5.30
The ADAM metalloproteinases. Mol Aspects Med (2008) 4.34
Unusually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med (1982) 4.05
Mechanoenzymatic cleavage of the ultralarge vascular protein von Willebrand factor. Science (2009) 3.85
A potential fusion peptide and an integrin ligand domain in a protein active in sperm-egg fusion. Nature (1992) 3.71
Epilepsy-related ligand/receptor complex LGI1 and ADAM22 regulate synaptic transmission. Science (2006) 3.52
Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood (1996) 3.39
Adam meets Eph: an ADAM substrate recognition module acts as a molecular switch for ephrin cleavage in trans. Cell (2005) 3.34
Functional analysis of the domain structure of tumor necrosis factor-alpha converting enzyme. J Biol Chem (2000) 2.92
The ADAMs: signalling scissors in the tumour microenvironment. Nat Rev Cancer (2008) 2.90
FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay. Br J Haematol (2005) 2.86
ADAMs in cancer cell proliferation and progression. Cancer Sci (2007) 2.69
A disintegrin-like and metalloprotease (reprolysin-type) with thrombospondin type 1 motif (ADAMTS) superfamily: functions and mechanisms. J Biol Chem (2009) 2.49
Inflammatory skin and bowel disease linked to ADAM17 deletion. N Engl J Med (2011) 2.41
Early evolution of the venom system in lizards and snakes. Nature (2005) 2.40
The "a disintegrin and metalloprotease" (ADAM) family of sheddases: physiological and cellular functions. Semin Cell Dev Biol (2008) 2.31
Crystal structure of the TSP-1 type 1 repeats: a novel layered fold and its biological implication. J Cell Biol (2002) 2.28
Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor. Proc Natl Acad Sci U S A (1990) 2.23
Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity. Proc Natl Acad Sci U S A (2002) 2.23
Shear stress enhances the proteolysis of von Willebrand factor in normal plasma. Blood (1994) 2.12
Cleavage of von Willebrand factor requires the spacer domain of the metalloprotease ADAMTS13. J Biol Chem (2003) 2.12
Exosite interactions contribute to tension-induced cleavage of von Willebrand factor by the antithrombotic ADAMTS13 metalloprotease. Proc Natl Acad Sci U S A (2006) 2.07
ADAMTS-13 cysteine-rich/spacer domains are functionally essential for von Willebrand factor cleavage. Blood (2003) 2.06
Recent advances in thrombotic thrombocytopenic purpura. Hematology Am Soc Hematol Educ Program (2004) 1.94
Thiol isomerases negatively regulate the cellular shedding activity of ADAM17. Biochem J (2010) 1.93
Structural specializations of A2, a force-sensing domain in the ultralarge vascular protein von Willebrand factor. Proc Natl Acad Sci U S A (2009) 1.91
Von Willebrand factor, platelets and endothelial cell interactions. J Thromb Haemost (2003) 1.91
Proteolytic processing of a protein involved in sperm-egg fusion correlates with acquisition of fertilization competence. J Cell Biol (1990) 1.90
Structural aspects of the metzincin clan of metalloendopeptidases. Mol Biotechnol (2003) 1.87
A secreted form of ADAM9 promotes carcinoma invasion through tumor-stromal interactions. Cancer Res (2005) 1.87
Essential role of the disintegrin-like domain in ADAMTS13 function. Blood (2009) 1.86
Gain-of-function ADAMTS13 variants that are resistant to autoantibodies against ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura. Blood (2012) 1.83
ADAMTSL2 mutations in geleophysic dysplasia demonstrate a role for ADAMTS-like proteins in TGF-beta bioavailability regulation. Nat Genet (2008) 1.78
Extensive contacts between ADAMTS13 exosites and von Willebrand factor domain A2 contribute to substrate specificity. Blood (2008) 1.74
The proximal carboxyl-terminal domains of ADAMTS13 determine substrate specificity and are all required for cleavage of von Willebrand factor. J Biol Chem (2005) 1.73
ADAM, a widely distributed and developmentally regulated gene family encoding membrane proteins with a disintegrin and metalloprotease domain. Dev Biol (1995) 1.73
Proteases involved in cartilage matrix degradation in osteoarthritis. Biochim Biophys Acta (2011) 1.73
Crystal structure of the catalytic domain of human tumor necrosis factor-alpha-converting enzyme. Proc Natl Acad Sci U S A (1998) 1.70
Proteolytic activities of human ADAMTS-5: comparative studies with ADAMTS-4. J Biol Chem (2007) 1.66
The cysteine-rich domain of human ADAM 12 supports cell adhesion through syndecans and triggers signaling events that lead to beta1 integrin-dependent cell spreading. J Cell Biol (2000) 1.63
A homozygous mutation in ADAMTSL4 causes autosomal-recessive isolated ectopia lentis. Am J Hum Genet (2009) 1.63
Structural considerations of the snake venom metalloproteinases, key members of the M12 reprolysin family of metalloproteinases. Toxicon (2005) 1.61
Snake venom metalloproteinases: their role in the pathogenesis of local tissue damage. Biochimie (2000) 1.60
Matrix metalloproteinases: fold and function of their catalytic domains. Biochim Biophys Acta (2009) 1.58
VWF73, a region from D1596 to R1668 of von Willebrand factor, provides a minimal substrate for ADAMTS-13. Blood (2003) 1.55
Snake venomics. Strategy and applications. J Mass Spectrom (2007) 1.54
Hemorrhagic metalloproteinases from snake venoms. Pharmacol Ther (1994) 1.50
Translational development of an ADAMTS-5 antibody for osteoarthritis disease modification. Osteoarthritis Cartilage (2015) 1.48
Crystal structures of the noncatalytic domains of ADAMTS13 reveal multiple discontinuous exosites for von Willebrand factor. Proc Natl Acad Sci U S A (2009) 1.45
Snake venom disintegrins: evolution of structure and function. Toxicon (2005) 1.43
Cleavage of the ADAMTS13 propeptide is not required for protease activity. J Biol Chem (2003) 1.39
Crystal structures of the two major aggrecan degrading enzymes, ADAMTS4 and ADAMTS5. Protein Sci (2007) 1.36
First structure of a snake venom metalloproteinase: a prototype for matrix metalloproteinases/collagenases. EMBO J (1993) 1.36
Ectodomain shedding and ADAMs in development. Development (2012) 1.34
Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor. Blood (2011) 1.33
Biology and physics of von Willebrand factor concatamers. J Thromb Haemost (2011) 1.33
Catalytic domain architecture of metzincin metalloproteases. J Biol Chem (2009) 1.31
Crystal structures of VAP1 reveal ADAMs' MDC domain architecture and its unique C-shaped scaffold. EMBO J (2006) 1.30
Hemorrhage induced by snake venom metalloproteinases: biochemical and biophysical mechanisms involved in microvessel damage. Toxicon (2005) 1.29
Domain loss facilitates accelerated evolution and neofunctionalization of duplicate snake venom metalloproteinase toxin genes. Mol Biol Evol (2011) 1.29
Insights into and speculations about snake venom metalloproteinase (SVMP) synthesis, folding and disulfide bond formation and their contribution to venom complexity. FEBS J (2008) 1.28
An autoantibody epitope comprising residues R660, Y661, and Y665 in the ADAMTS13 spacer domain identifies a binding site for the A2 domain of VWF. Blood (2009) 1.27
Cross-domain inhibition of TACE ectodomain. Proc Natl Acad Sci U S A (2011) 1.26
The ADAM10 prodomain is a specific inhibitor of ADAM10 proteolytic activity and inhibits cellular shedding events. J Biol Chem (2007) 1.22
Snake venom metalloendopeptidases: reprolysins. Methods Enzymol (1995) 1.21
Coagulation factor X activating enzyme from Russell's viper venom (RVV-X). A novel metalloproteinase with disintegrin (platelet aggregation inhibitor)-like and C-type lectin-like domains. J Biol Chem (1992) 1.20
Enzymatic toxins from snake venom: structural characterization and mechanism of catalysis. FEBS J (2011) 1.19
Crystal structures of human ADAMTS-1 reveal a conserved catalytic domain and a disintegrin-like domain with a fold homologous to cysteine-rich domains. J Mol Biol (2007) 1.18
Type I procollagen N-proteinase from chick embryo tendons. Purification of a new 500-kDa form of the enzyme and identification of the catalytically active polypeptides. J Biol Chem (1989) 1.18
Protein complexes in snake venom. Cell Mol Life Sci (2009) 1.17
The ADAMTS (A Disintegrin and Metalloproteinase with Thrombospondin motifs) family. Genome Biol (2015) 1.16
Exploring snake venom proteomes: multifaceted analyses for complex toxin mixtures. Proteomics (2008) 1.16
Amino acid residues Arg(659), Arg(660), and Tyr(661) in the spacer domain of ADAMTS13 are critical for cleavage of von Willebrand factor. Blood (2010) 1.16
Structural interaction of natural and synthetic inhibitors with the venom metalloproteinase, atrolysin C (form d). Proc Natl Acad Sci U S A (1994) 1.14
ADAM13 disintegrin and cysteine-rich domains bind to the second heparin-binding domain of fibronectin. J Biol Chem (2002) 1.12
Crystal structure of the catalytic domain of human ADAM33. J Mol Biol (2004) 1.12
Structure of coagulation factors IX/X-binding protein, a heterodimer of C-type lectin domains. Nat Struct Biol (1997) 1.11
Crystal structure of an anticoagulant protein in complex with the Gla domain of factor X. Proc Natl Acad Sci U S A (2001) 1.10
Crystal structure of trimestatin, a disintegrin containing a cell adhesion recognition motif RGD. J Mol Biol (2003) 1.10
Nardilysin enhances ectodomain shedding of heparin-binding epidermal growth factor-like growth factor through activation of tumor necrosis factor-alpha-converting enzyme. J Biol Chem (2006) 1.07
High resolution crystal structure of the catalytic domain of ADAMTS-5 (aggrecanase-2). J Biol Chem (2007) 1.05
Three-dimensional domain architecture of the ADAM family proteinases. Semin Cell Dev Biol (2008) 1.05
Intermediate reactions in the coagulation of blood with tissue thromboplastin; convertin, accelerin, prothrombinase. Scand J Clin Lab Invest (1957) 1.02
Polymerase chain reaction selects a novel disintegrin proteinase from CD40-activated germinal center dendritic cells. J Exp Med (1997) 1.02
Evolution of snake venom disintegrins by positive Darwinian selection. Mol Biol Evol (2008) 1.02
Allosteric activation of ADAMTS13 by von Willebrand factor. Proc Natl Acad Sci U S A (2014) 1.02
ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura. Annu Rev Med (2015) 1.02
Separation from Russell's viper venom of one fraction reacting with factor X and another reacting with factor V. Biochemistry (1969) 1.02
Snake venom metalloproteinases. Toxicon (2012) 1.02
Conformational activation of ADAMTS13. Proc Natl Acad Sci U S A (2014) 1.01
Evolution of disintegrin cysteine-rich and mammalian matrix-degrading metalloproteinases: gene duplication and divergence of a common ancestor rather than convergent evolution. J Mol Evol (1996) 1.01